Literature DB >> 332381

Adrenergic control of hypothalamic function during osmotic stress in the mallard duck (Anas platyrhynchos).

D L Hoffman, J H Abel, T H McNeill.   

Abstract

The role of the paraventricular nucleus (PVN) and biogenic amines (BA) in regulating the level of corticoids in the serum of osmotically stressed mallard ducks (Anas platyrhynchos) was analyzed employing three experimental approaches: 1) pharmacologic alteration of central BA levels, 2) microscopic evaluation of BA distribution, and 3) placement of electrolytic lesions into the PVN. Reserpine and alpha-methyl-p-tyrosine (alphampt), agents that decrease the amount of BA's in the central nervous system, produced a fivefold increase in the concentration of serum corticoids. Conversely, pargyline and amphetamine, agents that increase the functional pool of BA's, prevented the rise in serum corticoid concentration normally observed in birds challenged with an intraperitoneal injection of hypertonic saline. When the topographic distribution of BA's was analyzed in the brains of osmotically stressed and nonstressed ducks distinct changes in the intensity of catecholamine (CA) fluorescence were observed in only bone location, the PVN of the hypothalamus. Additionally, electrolytic lesions stereotaxically placed in the PVN blocked the osmotic stress-induced rise in serum corticoid concentration. These data therefore indicate that the PVN in the mallard duck plays some role in regulating the observed stress-induced rise in serum corticoid concentration, and that this regulatory function is probably inhibited by catecholamines.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 332381     DOI: 10.1007/bf00220587

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  40 in total

1.  EVIDENCE OF INHIBITIVE ROLE OF HIPPOCAMPUS IN NEURAL REGULATION OF ACTH RELEASE.

Authors:  K M KNIGGE; M HAYS
Journal:  Proc Soc Exp Biol Med       Date:  1963-10

2.  EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. IV. DISTRIBUTION OF MONOAMINE NERVE TERMINALS IN THE CENTRAL NERVOUS SYSTEM.

Authors:  K FUXE
Journal:  Acta Physiol Scand Suppl       Date:  1965

3.  Salt glands.

Authors:  K SCHMIDT-NIELSEN
Journal:  Sci Am       Date:  1959-01       Impact factor: 2.142

4.  The hypothalamo-hypophysial neurosecretory system of the white-crowned sparrow, Zonotrichia leucophrys gambelii.

Authors:  A OKSCHE; D F LAWS; F I KAMEMOTO; D S FARNER
Journal:  Z Zellforsch Mikrosk Anat       Date:  1959

5.  Regulation of electrolyte balance in marine birds with special reference to the role of the pituitary-adrenal axis in the duck (Anas platyrhynchos).

Authors:  W N Holmes
Journal:  Fed Proc       Date:  1972 Nov-Dec

6.  Effect of osmotic stress and hormone therapy on the hypothalamus of the duck (Anas platyrhynchos).

Authors:  R W Rhees; J H Abel; J R Frame
Journal:  Neuroendocrinology       Date:  1972       Impact factor: 4.914

7.  Neurohistological studies of the hypothalamo-hypophysial system of Zonotrichia leucophrys gambelii (Aves, Passeriformes).

Authors:  A Oksche; D S Farner
Journal:  Adv Anat Embryol Cell Biol       Date:  1974       Impact factor: 1.231

8.  Stereotaxic mapping of the monoamine pathways in the rat brain.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

9.  Neural connections of the "visual wulst" of the avian telencephalon. Experimental studies in the piegon (Columba livia) and owl (Speotyto cunicularia).

Authors:  H J Karten; W Hodos; W J Nauta; A M Revzin
Journal:  J Comp Neurol       Date:  1973-08       Impact factor: 3.215

10.  Effects of arginine vasotocin on the salt gland of the goose, Anser anser.

Authors:  M Peaker
Journal:  J Endocrinol       Date:  1971-03       Impact factor: 4.286

View more
  1 in total

1.  Immunocytochemical investigation of the hypothalamo-neurohypophysial system in birds.

Authors:  N Goossens; S Blähser; A Oksche; F Vandesande; K Dierickx
Journal:  Cell Tissue Res       Date:  1977-10-21       Impact factor: 5.249

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.